Cesca Therapeutics Inc.

4:00 PM - 4:15 PM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
Cesca Therapeutics Inc. is a market leader in cell processing technologies and autologous cell therapies for regenerative medicine. Its device division, ThermoGenesis, develops, commercializes and markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. The Company’s automated, functionally-closed CAR-TXpress™ platform is designed to streamline the manufacturing process for the emerging CAR-T immunotherapy market
Ticker:
KOOL
Exchange:
NASDAQ
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
1986
Main Therapeutic Focus:
Lead Product in Development:
CAR-TXpress Platfrom
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Principal Accounting Officer
Cesca Therapeutics Inc.